Skip to content

Clinical trials

Phase 3 Digestive System Diseases trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Digestive System Diseases Phase: Phase 3 Country / region: France Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20091
20101
20111
20121
20141
20162
20171
20191
20201
20243
20255
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Recruiting6
Active, not recruiting3
Not yet recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
89bio, Inc.2
Mirum Pharmaceuticals, Inc.2
Sumitomo Pharma America, Inc.2
Zealand Pharma2
Abbott1
Assistance Publique - Hôpitaux de Paris1
Baxter Healthcare Corporation1
Celgene1
Centre Francois Baclesse1
GCS Ramsay Santé pour l'Enseignement et la Recherche1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Digestive System Diseases21
Liver Diseases7
Digestive System Neoplasms6
Neoplasms by Site6
Gastrointestinal Diseases5
Intestinal Diseases5
Neoplasms4
Pancreatic Diseases4
Adenocarcinoma3
Colorectal Neoplasms3

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.